BridgeMD
New treatment option for Takotsubo Cardiomyopathy
Official title Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
ClinicalTrials.gov ID: NCT04513054
What this study is testing
What is Blood collection for genetic analysis?
Blood collection for genetic analysis is an investigational medicine, being studied as a potential treatment for takotsubo cardiomyopathy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date.
- Familial cases elsewhere in the world who would be willing to participate.
You likely can't join if
- Unwillingness to participate
The study team makes the final eligibility decision.
Where it's taking place
- Aberdeen, Aberdeenshire, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aberdeen, Aberdeenshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.